The typical worker in biopharma made $116,648 in 2025, according to an Endpoints News pay analysis, earning about 30% more than the typical employee of an S&P 500 company.
The typical worker in biopharma made $116,648 in 2025, according to an Endpoints News pay analysis, earning about 30% more than the typical employee of …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Endpoints launches its annual biopharma pay project; Andrew Dunn and Drew Armstrong break down CEO compensation live on June 9,…
Biopharma's 10 highest-paid CSOs and CMOs in 2025: Lilly's Dan Skovronsky led at $17.8M, with nine others topping $10M.
Twelve biopharma execs collected nearly $1B in golden parachutes from 2025–26 M&A deals, led by Cidara's Jeffrey Stein ($221M)…
Biopharma sales trended upward in the first quarter of this year as eight of the industry’s top-25 companies achieved…
Biopharma's mood keeps climbing: BPSI hits 96 in Q2 2026. Inside: the biotech-pharma hiring chasm, a record M&A pace and s…
As the health insurance industry continues to face significant headwinds and challenges, the CEOs of major firms largely stayed…
